Advertisement

Advertisement

INO Stock Latest News

Inovio price target lowered to $2.50 from $3 at H.C. Wainwright

The FlyInovio price target lowered to $2.50 from $3 at H.C. Wainwright

Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100

PremiumThe Fly

Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100

16d ago

Inovio Shareholders Endorse Governance Changes and Leadership

PremiumCompany Announcements

Inovio Shareholders Endorse Governance Changes and Leadership

17d ago

Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze

PremiumCompany Announcements

Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze

18d ago

Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain

PremiumCompany Announcements

Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain

23d ago

Inovio reports Q1 EPS (28c), consensus (33c)

PremiumThe FlyInovio reports Q1 EPS (28c), consensus (33c)

24d ago

Inovio options imply 15.1% move in share price post-earnings

The Fly

Inovio options imply 15.1% move in share price post-earnings

24d ago

Options Volatility and Implied Earnings Moves Today, May 13, 2026

Market News

Options Volatility and Implied Earnings Moves Today, May 13, 2026

25d ago

Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026

PremiumMarket News

Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026

27d ago

Is INO a Buy, Before Earnings?

PremiumPre-Earnings

Is INO a Buy, Before Earnings?

27d ago

Inovio Pharmaceuticals Announces New Public Equity Offering

PremiumCompany Announcements

Inovio Pharmaceuticals Announces New Public Equity Offering

2M ago

Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program

PremiumCompany Announcements

Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program

2M ago

Inovio files to sell common stock, no amount given

PremiumThe FlyInovio files to sell common stock, no amount given

2M ago

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

Market News

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

3M ago

Inovio’s Earnings Call: INO-3107 Drives 2026 Focus

Company Announcements

Inovio’s Earnings Call: INO-3107 Drives 2026 Focus

3M ago

Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target

PremiumRatings

Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target

3M ago

Inovio reports Q4 EPS (26c), consensus (34c)

PremiumThe Fly

Inovio reports Q4 EPS (26c), consensus (34c)

3M ago

Options Volatility and Implied Earnings Moves Today, March 12, 2026

PremiumMarket News

Options Volatility and Implied Earnings Moves Today, March 12, 2026

3M ago

Inovio, Akeso announce clinical collaboration

PremiumThe Fly

Inovio, Akeso announce clinical collaboration

3M ago

Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback

PremiumClass ActionInovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback

3M ago

INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?

3M ago

Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop

Class Action

Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >